1,122 Shares in Danaher Co. (NYSE:DHR) Purchased by Advisor Resource Council

Advisor Resource Council acquired a new stake in Danaher Co. (NYSE:DHR) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,122 shares of the conglomerate’s stock, valued at approximately $260,000.

A number of other institutional investors also recently modified their holdings of DHR. Tsfg LLC lifted its holdings in Danaher by 733.3% during the 1st quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after buying an additional 88 shares in the last quarter. Cape Investment Advisory Inc. bought a new stake in shares of Danaher during the fourth quarter worth $25,000. BKM Wealth Management LLC acquired a new position in shares of Danaher during the fourth quarter valued at $27,000. Redmont Wealth Advisors LLC acquired a new stake in shares of Danaher during the 1st quarter worth approximately $30,000. Finally, Wetzel Investment Advisors Inc. bought a new position in shares of Danaher in the 4th quarter worth $29,000. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Jefferies Financial Group assumed coverage on Danaher in a research note on Monday, June 3rd. They set a “buy” rating and a $295.00 target price for the company. TD Cowen boosted their price target on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research report on Wednesday, April 24th. HSBC upgraded Danaher from a “hold” rating to a “buy” rating and upped their price objective for the stock from $250.00 to $280.00 in a research note on Wednesday, April 17th. Bank of America raised their target price on shares of Danaher from $258.00 to $270.00 and gave the company a “neutral” rating in a research note on Wednesday, April 24th. Finally, Evercore ISI cut their price target on shares of Danaher from $266.00 to $260.00 and set an “outperform” rating for the company in a research note on Tuesday. Six equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $268.67.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 4,000 shares of the stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $250.01, for a total value of $1,000,040.00. Following the transaction, the senior vice president now owns 29,830 shares in the company, valued at $7,457,798.30. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, SVP Brian W. Ellis sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $250.01, for a total transaction of $1,000,040.00. Following the transaction, the senior vice president now directly owns 29,830 shares of the company’s stock, valued at $7,457,798.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Rainer Blair sold 9,005 shares of the stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $265.00, for a total transaction of $2,386,325.00. Following the completion of the sale, the chief executive officer now owns 106,990 shares of the company’s stock, valued at approximately $28,352,350. The disclosure for this sale can be found here. Insiders sold 148,783 shares of company stock valued at $37,536,717 in the last three months. Corporate insiders own 10.90% of the company’s stock.

Danaher Trading Down 0.2 %

Shares of NYSE DHR opened at $240.00 on Friday. The firm has a 50 day moving average price of $255.67 and a two-hundred day moving average price of $246.91. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.51 and a current ratio of 1.85. The stock has a market cap of $177.77 billion, a P/E ratio of 40.68, a price-to-earnings-growth ratio of 3.67 and a beta of 0.83. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $269.11.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. The business had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The business’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.36 earnings per share. As a group, equities analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.27 dividend. The ex-dividend date is Friday, June 28th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s dividend payout ratio is presently 18.31%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.